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In Xenopus, primitive blood originates from the mesoderm, but extrinsic signals from the ectoderm are required during gastrulation to enable
these cells to differentiate as erythrocytes. The nature of these signals, and how they are transcriptionally regulated, is not well understood. We
have previously shown that bone morphogenetic proteins (BMPs) are required to signal to ectodermal cells to generate secondary non-cell-
autonomous signal(s) necessary for primitive erythropoiesis, and that calmodulin-dependent protein kinase IV (CaM KIV) antagonizes BMP
signaling. The current studies demonstrate that Gata-2 functions downstream of BMP receptor activation in these same cells, and is a direct target
for antagonism by CaM KIV. We show, using loss of function analysis in whole embryos and in explants, that ectodermal Gata-2 is required for
primitive erythropoiesis, and that BMP signals cannot rescue blood defects caused by ectoderm removal or loss of ectodermal GATA-2.
Furthermore, we provide evidence that acetylation of GATA-2 is required for its function in primitive blood formation in vivo. Our data support a
model in which Gata-2 is a transcriptional target downstream of BMPs within ectodermal cells, while activation of the CaM KIV signaling
pathway alters GATA-2 function posttranslationally, by inhibiting its acetylation.
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In vertebrates, embryonic hematopoiesis occurs in two
distinct phases. The first phase, known as primitive hematopoi-
esis, occurs during early embryogenesis and gives rise primarily
to red blood cells (RBCs), but also some white blood cells
(WBCs). Primitive blood is generated in the extraembryonic
yolk sac in mammalian embryos, and in the intraembryonic
ventral blood island (VBI) in Xenopus laevis (Galloway and
Zon, 2003). The second phase of hematopoiesis is known as
definitive hematopoiesis and generates multipotent hemato-
poietic stem cells. Definitive hematopoiesis is initiated in the
aorta, gonads and mesonephros region in mammals (Cumano et⁎ Corresponding author. Fax: +1 503 494 4253.
E-mail address: christia@ohsu.edu (J.L. Christian).
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doi:10.1016/j.ydbio.2007.08.012al., 1996; Godin et al., 1993; Medvinsky and Dzierzak, 1996;
Medvinsky et al., 1993) and in an analogous region, the dorsal
lateral plate in Xenopus (Kau and Turpen, 1983; Maeno et al.,
1985; Weber et al., 1991).
Embryological experiments have shown that signals derived
from non-hematopoietic tissues are essential for normal
primitive erythropoiesis (Baron, 2003). In Xenopus, numerous
lines of evidence suggest that ectodermal cells, which come
into contact with underlying ventral mesoderm during
gastrulation, serve as an important source of such signals
(Maeno, 2003). For instance, when embryos are induced to
exogastrulate, which prevents the prospective ectoderm from
coming into contact with the mesoderm, primitive erythrocytes
fail to differentiate although other mesodermal cell types
develop normally (Kikkawa et al., 2001). Furthermore, when
ventral mesoderm, which gives rise to the bulk of the posterior
VBI (Ciau-Uitz et al., 2000; Lane and Sheets, 2002; Lane and
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gastrula stage (stage 10) and cultured in isolation to the tailbud
stage, it fails to form blood cells (Maeno et al., 1994b; Maeno
and Kung, 1992). Blood formation can be restored, however,
by co-culturing the ventral mesoderm with ectoderm isolated
from late blastula or gastrula stage embryos (Maeno et al.,
1994b). By the early neurula stage (stage 16), ventral meso-
dermal explants can differentiate as RBCs when cultured in
isolation, suggesting that extrinsic signals essential for hema-
topoiesis are transmitted between early gastrula and neurula
stages (Maeno et al., 1994b).
We have shown that cross talk between the bone morpho-
genetic protein (BMP) and calmodulin-dependent kinase IV
(CaM KIV) pathways within ectodermal cells is required for
normal primitive erythropoiesis (Walters et al., 2002). When
BMP signal reception is blocked within ectodermal cells, or
when CaM KIV is constitutively activated within these same
cells, hematopoietic mesoderm is specified normally but fewer
differentiated RBCs are present, due at least in part to an
increase in apoptosis. Further analysis revealed that CaM KIV
functions downstream of BMP receptor activation to inhibit
hematopoiesis.
Our previous studies suggested a molecular mechanism for
cross talk between the BMP and CaM KIV pathways. CaM KIV
functions predominantly in the nucleus where it phosphorylates
a number of transcription factors, the best characterized of
which is CREB (reviewed by Soderling, 1999). Once
phosphorylated, CREB can recruit the transcriptional co-
activator, CREB binding protein (CBP, or the closely related
ortholog, p300), and this binding enables CREB to activate
transcription of target genes (Cardinaux et al., 2000). We
showed that overexpression of a constitutively active form of
CREB, which can interact with CBP in the absence of
phosphorylation, phenocopies the blood defects caused by
loss of BMPs or constitutive activation of CaM KIV, even when
the DNA binding domain is deleted (Walters et al., 2002). By
contrast, overexpression of a form of CREB that is unable to
bind CBP in the absence of phosphorylation has no effect on
hematopoiesis. These findings suggest that the ability of CaM
KIV to inhibit hematopoiesis does not require activation of
CaM KIV target genes. Instead, our data support a molecular
model in which CaM KIV inhibits the BMP pathway by
activating a substrate that competes with transcriptional com-
plexes downstream of BMP receptor activation for binding to
limiting amounts of CBP.
Given that CBP is an essential cofactor for the BMP receptor
activated transcription factors, Smad 1, 5 and/or 8 (Massague
and Wotton, 2000), one simple possibility is that a CaM KIV
substrate competes directly with these Smads for binding to
CBP, thereby blocking transcription of all BMP target genes.
Inconsistent with this scenario, however, constitutive activation
of the CaM KIV pathway in Xenopus embryos selectively
inhibits the ability of BMP to transduce signals that are required
for hematopoiesis, but does not interfere with BMP-mediated
specification of epidermal fate (Walters et al., 2002), which is
known to require Smad/CBP interactions (Kato et al., 1999).
These findings suggest the involvement of a distinct, hemato-poietic-specific transcription factor that functions downstream
of BMP receptor activation and is the direct target for CaM
KIV-mediated antagonism.
GATA-2 is an excellent candidate for a transcription factor
that functions in ectodermal cells in concert with BMPs and
CaM KIV during hematopoiesis. GATA-2 is a zinc finger
transcription factor that recruits CBP as a cofactor to activate
target genes (Blobel et al., 1998). Loss of function studies in
mice have demonstrated that Gata-2 is essential for both
primitive and definitive hematopoiesis (Fujiwara et al., 2004;
Tsai et al., 1994). In Xenopus, zygotic expression of Gata-2 is
first detected at the early gastrula stage in ectodermal cells and
later expands into the ventral mesoderm (Kelley et al., 1994;
Walmsley et al., 1994; Zon et al., 1991).
Several lines of evidence suggest that Gata-2 is a direct
target gene downstream of BMPs. First, inhibition of BMP
activity in whole Xenopus embryos leads to downregulation of
Gata-2 expression in the mesoderm, and less so in the ectoderm
(Maeno et al., 1996; Walmsley et al., 1994). Second, BMP-4
can induce expression of Gata-2 in whole Xenopus embryos in
the absence of new protein synthesis suggesting a direct
transcriptional mechanism, although it is not clear whether this
induction occurs in mesodermal cells, ectodermal cells or both
(Friedle and Knochel, 2002).
A potential role for ectodermally derived Gata-2 in blood
development has been suggested based on ectopic expression
studies. Specifically, ventral mesoderm explanted from a
gastrula stage embryo can differentiate as blood if it is co-
cultured with ectoderm isolated from a mid-blastula stage (stage
8) or older embryo but not if it is co-cultured with ectoderm
isolated at stage 7 (Maeno et al., 1996, 1994b). Ectopic
expression of GATA-2, however, is sufficient to make
ectodermal cells isolated from stage 7 embryos competent to
support blood formation in co-cultured ventral mesoderm
(Maeno et al., 1996).
In the present study, we present loss of function data in whole
embryos and explants showing that ectodermal Gata-2 is
required to activate a secondary signal that acts across germ
layers and is essential for the differentiation of erythroid
progenitors. Furthermore, we provide evidence that Gata-2
functions downstream of BMP receptor activation and is a direct
target for antagonism by CaM KIV. Our results support a model
in which CaM KIV activates a substrate that binds to, and
prevents CBP from acetylating, GATA-2 thereby inhibiting its
ability to activate transcription of target gene(s).Materials and methods
Embryo culture and manipulation
Ovulation was induced by injecting female frogs with human chorionic
gonadotropin (Sigma). Embryonic stages are according to Nieuwkoop and
Faber (1967). Capped synthetic mRNA was synthesized by in vitro
transcription of linearized template cDNAs using a MegaScript kit (Ambion)
and injected into embryos as described previously (Moon and Christian, 1989).
Embryo explants and recombinants were generated and cultured in half strength
normal amphibian medium (NAM/2; Peng, 1991) as described (Goldman et al.,
2006).
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Morpholino antisense oligonucleotides (MOs) complimentary to two dif-
ferent alleles of Gata-2 (GATA-2a: 5′-CTTCCATCGCAGGAGCAAA-
GTTCTC and GATA-2b: 5′-GGTCAGTAGCCACTTCCATTGCAGG) and a
standard control MO were purchased from Gene Tools, LLC (Philomath, OR).
Equal amounts of the two GATA-2 MOs were mixed and the dose titrated to 6–
20 ng per embryo to give a specific, rescuable loss of RBCs. A second batch of
the same MOs was purchased subsequently and a higher dose (40–60 ng total
per embryo) was required to obtain the same results. Sequence encoding an HA
epitope tag was appended to the 3′ end of the GATA-2 open reading frame by
PCR-mediated amplification. The GATA-2 HA cDNA was amplified by PCR
using an oligonucleotide containing silent mutations (5′ATGGAGGTTGC-
CACCGAT; silent mutations in bold and translation start site in italic) that
prevent annealing of the GATA-2 MOs to generate rGATA-2 HA. cDNAs were
subcloned into pCS2+ for RNA transcription. Mutation of Serine 385 and of
putative acetylated lysine residues was accomplished using the PCR-based
splicing by overlap extension technique (Horton et al., 1990) and appropriate
primers. Regions of cDNAs generated by PCR were sequenced.
Analysis of RNA and protein expression
Total RNA was isolated and Northern blots were hybridized with antisense
riboprobes as described previously (Christian and Moon, 1993). Bands were
visualized with a phosphoimager and quantified using the Macintosh IP lab gel
program. Embryos were stained for β-galactosidase activity using Red-gal as a
substrate, and processed for in situ hybridization as described previously
(Nakayama et al., 1998).
Xenopus embryos were lysed and subject to Freon extraction as described
(Moon and Christian, 1989). Proteins were separated by electrophoresis on an
11% polyacrylamide gel and transferred onto PVDF membrane. Membranes
were probed with anti-HA (3F10; Roche) antibody and immunoreactive proteins
detected by chemiluminescence. Whole mount immunostaining was performed
as described (Moon and Christian, 1989).
Collection and analysis of peripheral blood samples
Tails were severed from tadpoles and blood collected into medium
containing 0.7×PBS, 0.5% BSA and 10 IU/ml of heparin. Cells were
concentrated onto slides using a cytocentrifuge and stained with a Hema 3
stain set (Fisher Diagnostics). A minimum of 24 embryos was bled per
experimental group and, for each embryo, the number of cells in five random
fields was counted at 40× magnification. Each experiment was repeated a
minimum of three times and results were pooled.Results
Downregulation of GATA-2 inhibits primitive erythropoiesis
To begin to test whether ectodermal Gata-2 is required for
primitive hematopoiesis, we designed antisense morpholino
oligonucleotides (MOs) that could be used to block translation
of endogenous Gata-2 mRNAs. Western blot analysis showed
that GATA-2 MOs, but not control MOs, efficiently blocked
translation of RNA encoding an HA-epitope-tagged version of
GATA-2 (GATA-2 HA) when the two were co-expressed in
Xenopus embryos (Fig. 1A). By contrast, GATA-2 MOs did
not block translation of a rescue construct (rGATA-2 HA)
containing silent mutations that prevent annealing of the MOs
(see Materials and methods). GATA-2 or control MOs (6 ng)
were then targeted to prospective dorsoanterior or ventropos-
terior ectodermal blastomeres of eight-cell embryos, together
with the lineage tracer β-galactosidase (100 pg), as illustrated inFig. 1B. These blastomeres make only a minor contribution, if
any, to erythroid cells in the VBI (Lane and Smith, 1999; Mills
et al., 1999). Embryos were cultured until stage 32 and stained
for β-galactosidase activity to confirm the accuracy of
injections (Fig. 1B, red stain), followed by in situ hybridization
to detect expression of Globin, a marker of differentiated RBCs
(purple stain). Embryos injected with GATA-2 MOs appeared
grossly normal but showed a severe reduction in expression of
Globin relative to those injected with control MOs (Fig. 1B).
Northern blot analysis confirmed the reduction in Globin
transcripts in embryos injected with GATA-2 MOs (Fig. 1C).
Expression of Globin was fully rescued by co-injection of RNA
encoding rGATA-2 HA (500 pg) (Fig. 1C), demonstrating that
the observed phenotype is specifically due to knockdown of
endogenous Gata-2 translation. Injection of rGATA-2 HA
alone, at doses up to 1 ng, did not cause an increase or decrease
in levels of Globin transcripts (data not shown). These data
suggest that expression of Gata-2 within ectodermal cells is
required for normal primitive erythropoiesis.
GATA-2 function in ectodermal cells is required for
differentiation, but not specification of hematopoietic
mesoderm
A decrease in the initial specification of blood cells could
account for the decrease in Globin expression observed when
expression of Gata-2 is downregulated. To investigate this
possibility, we analyzed expression of stem cell leukemia
(Scl), a transcription factor that is expressed in hematopoietic
mesoderm early in embryogenesis and is proposed to specify
hematopoietic fate (Mead et al., 1998). GATA-2 or control
MOs were injected into dorsal animal pole blastomeres of
eight-cell embryos and expression of Scl was analyzed by
RT–PCR and in situ hybridization at neurula (st. 18–22) and
tailbud (st. 32–34) stages. GATA-2 morphants showed normal
levels of Scl transcripts at neurula stage (Figs. 2A and B) but
by tailbud stage, morphants showed a severe loss of
expression of Globin (data not shown) and Scl (Figs. 2A
and B) relative to uninjected or control MO injected siblings.
We also examined expression of another early marker of
hematopoietic fate, Gata-1, with similar results. Equivalent
levels of Gata-1 transcripts were detected in embryos injected
with control or GATA-2 MOs at the neurula stage (Fig. 2C)
but expression was decreased in morphants relative to controls
by the tailbud stage (Figs. 2C, D). As previously reported by
others (Kelley et al., 1994), we were unable to detect
expression of Gata-1 by in situ hybridization at the neurula
stage. Taken together, these data suggest that expression of
Gata-2 within ectodermal cells is required for normal
differentiation of primitive RBCs in Xenopus, but not for the
specification of hematopoietic fate.
GATA-2 function is required non-cell-autonomously in the
ectoderm to regulate erythropoiesis
A tissue recombination assay was used to more stringently
test whether GATA-2 function is required in ectodermal, as
Fig. 1. GATA-2 functions non-cell-autonomously to regulate the differentiation of erythrocytes in Xenopus. (A) Anti-HA immunoblot showing that GATA-2 MOs can
block the translation of GATA-2 HAmRNA in vivo but have no effect on translation of rGATA-2 HA RNA that has been modified to prevent the MOs from annealing.
Three embryo equivalents were loaded in each lane. (B) Two dorsal or ventral animal pole blastomeres of eight-cell embryos were injected with RNA encoding β-
galactosidase together with GATA-2 or control MOs as illustrated. Embryos were stained for β-galactosidase activity at stage 32 (red stain) followed by in situ
hybridization analysis of Globin expression (purple stain). (C) Two dorsal or ventral animal pole blastomeres of eight-cell embryos were injected with GATA-2 or
control MOs alone or together with rGATA-2 HA RNA and expression of Globin was analyzed by Northern blot at stage 32. Levels of Globin transcripts, normalized
relative to levels of Odc transcripts, are expressed as a percentage of control below each lane. Similar results were obtained in at least three experiments.
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poiesis. Previous studies have shown that explanted gastrula
stage ventral mesoderm cannot differentiate as RBCs unless it
is co-cultured with ectoderm (Maeno et al., 1996; Maeno et al.,
1994b). To determine whether GATA-2 function is required
within these ectodermal cells, we recombined gastrula stage
ventral mesoderm with ectoderm isolated from embryos
injected with either control, or GATA-2 MOs (10 ng), and
analyzed expression of Globin at the tailbud stage, as
illustrated in Fig. 3A. Globin was not expressed in ventral
mesodermal explants cultured in the absence of ectoderm (Fig.3B). Globin was robustly expressed in recombinants of ventral
mesoderm co-cultured with ectoderm isolated from control
embryos, but was barely detectable in explants of ventral
mesoderm cultured with ectoderm isolated from GATA-2
morphants. Downregulation of GATA-2 within the ectodermal
component of recombinants had no effect on expression of the
mesodermally derived myeloid marker gene, Xpox2 (Smith et
al., 2002), demonstrating that ectodermally derived GATA-2 is
not required for mesoderm differentiation per se. These data
demonstrate that Gata-2 function is required within ectodermal
cells to enable ventral mesoderm to differentiate as RBCs.
Fig. 2. Ectodermal GATA-2 is not required for specification of hematopoietic mesoderm. GATA-2 morpholinos were injected into dorsal animal pole cells of eight-cell
embryos and expression of Scl (A, B) or Gata-1 (C, D) was analyzed by RT–PCR (A, C) or by in situ hybridization (B, D) at neurula and/or tail bud stages as
indicated. Reverse transcriptase was omitted from one set of samples (–RT) as a control for genomic contamination. Levels of Scl or Gata-1 transcripts, normalized
relative to levels of Odc transcripts, are expressed as a percentage of control below each lane. Similar results were obtained in at least three experiments.
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a loss of BMP expression or activity
Bmp-2, -4 and -7 are all expressed in ectodermal cells during
gastrulation and it has been suggested that BMPs secreted from
the ectoderm are required for the differentiation of the adjacent
hematopoietic mesoderm as blood (Kumano et al., 1999). These
Bmps are thus attractive candidates for genes that are expressed
downstream of GATA-2 and then signal to ventral mesoderm to
enable it to differentiate as blood. To begin to investigate this
possibility, we analyzed expression of Bmp-2, -4 and -7 in
embryos and ectodermal explants in which GATA-2 was
downregulated. Embryos were injected with GATA-2 MOs
(10 ng) at the two cell stage, ectodermal explants isolated at
stage 9, and expression of Bmps analyzed by Northern blottingat stage 13. Sibling embryos were cultured to stage 34 and
expression of Globin was analyzed to verify that the GATA-2
MO was effective. Fairly equivalent levels of Bmp-2 and -4
transcripts were detected in control and GATA-2 morphant
embryos and explants at stage 13 (Fig. 4A). Expression of Bmp-
7 was significantly reduced in GATA-2 morphant whole
embryos, but not in ectodermal explants (Fig. 4A). By contrast,
expression of Globin was severely reduced in morphants at
stage 34 (data not shown). Thus, GATA-2 does not play a major
role in regulating ectodermal expression of Bmp-2, -4 or -7, at
least during gastrula stages.
As a more stringent test of whether the defects observed in
GATA-2 morphants are due to a loss of BMP function during
hematopoiesis, we used a tissue recombination assay to ask
whether constitutive activation of the BMP pathway in the
Fig. 3. Ectodermally derived GATA-2 is required for normal erythropoiesis. (A) Experimental design is illustrated schematically. (B) Ectoderm (ecto) explanted from
embryos injected with either control or GATA-2 MOs was co-cultured with explanted ventral mesoderm (VM) until siblings reached the tailbud stage at which time
expression of Globin, Odc and Xpox2 was analyzed by Northern hybridization. Similar results were obtained in at least three experiments.
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downregulation of GATA-2 in the ectoderm. As illustrated in
Fig. 4B, ectoderm isolated from gastrulae that had been injected
with control or GATA-2 MOs (10 ng) at the two-cell stage wasFig. 4. Hematopoietic defects in GATA-2morphants are not caused by a loss of Bmp ex
GATA-2 MOs (+), or not (−), ectodermal explants were isolated at stage 9, and cultu
embryos and ectodermal explants (Ecto) by Northern hybridization. (B, C) Ventral m
constitutively active BMP receptor (caALK) was cultured in isolation (C) or togeth
GATA-2 MOs (B) until siblings reached the tailbud stage. Expression of Globin a
normalized relative to levels of Odc transcripts, are expressed as a percentage of contrrecombined with similarly staged ventral mesoderm isolated
from uninjected embryos, or embryos in which RNA encoding a
constitutively form of the BMP receptor, ALK3, (caALK,
400 pg) was targeted to ventral cells. Recombinants werepression or activity. (A) Both blastomeres of two-cell embryos were injectedwith
red until stage 13. Expression of Bmp-2, -4, -7 and Odc was analyzed in whole
esoderm (VM) explanted from control embryos, or embryos made to express a
er with ectoderm (ecto) explanted from embryos injected with either control or
nd Odc was analyzed by Northern hybridization. Levels of Globin transcripts,
ol below each lane in B. Similar results were obtained in a duplicate experiment.
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expression of Globin was analyzed. This dose of caALK did not
cause morphological defects when targeted to ventral cells but
caused a loss of dorsoanterior structures when targeted to dorsal
cells of sibling embryos (data not shown), thereby demonstrat-
ing that BMP signaling had been upregulated. As previously
described, expression of Globin is readily detected in recom-
binants consisting of ectoderm and mesoderm isolated from
wild type embryos but much lower levels of Globin are detected
in recombinants containing ectoderm isolated from GATA-2
morphants. Activation of the BMP pathway in the ventral
mesoderm did not cause a reproducible increase in expression
of Globin in recombinants containing wild type mesoderm, nor
did it rescue expression of Globin in recombinants containing
ectoderm isolated from GATA-2 morphants in two separate
experiments (Fig. 4B). Furthermore, constitutive activation of
the BMP pathway in explanted ventral mesoderm was not
sufficient to enable these cells to differentiate as RBCs in the
absence of ectoderm (Fig. 4C). These data demonstrate that the
blood defects observed in GATA-2 morphants are not caused by
a subsequent loss of BMP expression or function.
Downregulation of ectodermal GATA-2 leads to a decrease in
RBC number
Peripheral blood samples from GATA-2 deficient tadpoles
were examined to determine whether downregulation of
GATA-2 phenocopies the loss of RBCs observed when BMP
function is blocked, or CaM KIV is constitutively activated in
ectodermal cells (Walters et al., 2002; Wayman et al., 2000).
GATA-2 or control MOs (6 ng) were injected into two dorsal or
ventral animal pole blastomeres of eight-cell embryos to
preferentially target ectodermal cells. Embryos were cultured to
stage 42 and peripheral blood cells from a minimum of 24
embryos in each experimental group were collected onto slides
and counted. GATA-2 morphants were grossly normal morpho-
logically and had normal appearing beating hearts, but showedFig. 5. Downregulation of ectodermal GATA-2 leads to a decrease in RBC number.
tadpoles. Arrows indicate RBCs, arrowheads indicate WBCs. (B) Mean number (±S.E
embryos in which control or GATA-2 MOs had been injected into dorsal (dor) or
percentage of cell number in uninjected control embryos. Results are pooled from ta dramatic decrease in the number of RBCs and a small, but
reproducible decrease in WBC number relative to sibling
controls (Figs. 5A, B).
GATA-2 functions downstream of BMP and CaM KIV signaling
in ectodermal cells
To begin to ask whether GATA-2, BMPs and CaM KIV
function in a common pathway within ectodermal cells to
regulate primitive erythropoiesis, we examined the effects of
simultaneously misregulating expression or function of these
molecules on RBC number.
When ectodermal BMP signal reception was blocked by
injection of RNA encoding a dominant negative BMP receptor
(tBR) (400 pg) or when GATA-2 expression was reduced by
injection of GATA-2 MOs into two dorsal blastomeres of eight-
cell embryos, the number of circulating RBCs was reduced to
approximately 40% of that in control embryos (Fig. 6A). The
results of this, and all subsequent experiments in which cell
number was used as an indicator of erythropoiesis, were verified
by Northern analysis of Globin expression at stage 33/34 (data
not shown). Simultaneous inhibition of BMP function and
GATA-2 expression led to an additive decrease in RBC number
to approximately 20% of that in controls. A similar additive
decrease in RBC number was observed when CaM KIV was
upregulated and GATA-2 was simultaneously downregulated.
As shown in Fig. 6B, co-injection of RNAs encoding
constitutively active forms of CaM KIV (50 pg) and its
upstream kinase, CaM KK (together referred to as KIVc)
(50 pg) together with GATA-2 MOs (6 ng) led to an additive
loss of RBCs relative to that observed when either pathway was
perturbed individually. These data are consistent with the
possibility that GATA-2 acts in the same or a parallel pathway to
BMPs and/or CaM KIV to regulate ectodermally derived
signals that are essential for primitive erythropoiesis.
To test the possibility that GATA-2 functions downstream of
BMPs, we asked whether overexpression of GATA-2 in(A) Wright–Giemsa-stained blood collected from control or GATA-2 morphant
.M.) of RBCs (red bars) andWBCs (white bars) present in tadpoles derived from
ventral (vent) animal pole blastomeres at the eight-cell stage, expressed as a
hree independent experiments.
Fig. 6. GATA-2 functions downstream of BMP and CaM KIV signaling in ectodermal cells. (A–D) Mean number (±S.E.M.) of RBCs present in tadpoles made to
express GATA-2MOs, a dominant mutant form of the BMP receptor (tBR), constitutively active CaMKIV (KIVc) and/or GATA-2 HA RNA as indicated, expressed as
a percentage of cell number in control embryos. (E) Experimental design is shown schematically. Mean number (±S.E.M.) of RBCs, expressed as a percentage of cell
number in control embryos, present in tadpoles in which CaM KIV signaling was upregulated in dorsal cells followed by injection of GATA-2 RNA into either the
same cells, or cells on the opposite side of the embryo as indicated. All results are pooled from a minimum of three independent experiments.
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blockade of BMP signaling in the same cells. Embryos injected
with RNA encoding tBR (400 pg) showed a greater than 50%
reduction in RBC number and this was completely rescued by
co-injection of RNA encoding GATA-2 HA (500 pg) (Fig. 6C).
The ability of GATA-2 to rescue erythropoiesis in BMP
deficient embryos is not compatible with a model in which
ectodermal GATA-2 functions as an obligatory hematopoietic
specific component of a transcriptional complex together with
Smad 1, 5 and/or 8 downstream of BMP receptor activation. A
more likely possibility is that BMPs activate transcription of
Gata-2 within ectodermal cells, and that GATA-2 then activates
transcription of a unique subset of genes that are required for
mesoderm to differentiate as blood. Consistent with this
possibility, previous studies have shown that BMPs are required
for transcription of Gata-2 in the ventral mesoderm, and
possibly also in the ectoderm (Friedle and Knochel, 2002;
Maeno et al., 1996; Walmsley et al., 1994).To ask whether GATA-2 also functions downstream of CaM
KIV, we injected embryos with RNA encoding constitutively
active components of the CaM KIV signaling cascade (50 pg
each) either alone, or together with RNA encoding GATA-2 HA
(500 pg). As shown in Fig. 6D, GATA-2 partially rescued the
loss of RBCs caused by constitutive activation of CaM KIV,
demonstrating that GATA-2 functions downstream of CaM KIV
during primitive hematopoiesis. The ability of GATA-2 to rescue
blood formation in these embryos might be explained if
activation of CaM KIV negatively regulates transcription of
Gata-2. Inconsistent with this idea, however, we have previously
shown that the ability of CaM KIV to inhibit erythropoiesis is
independent of transcription mediated by its downstream targets
(Walters et al., 2002). Furthermore, we were unable to detect any
change in expression ofGata-2 in whole embryos or ectodermal
explants in which CaM KIV was constitutively activated (data
not shown). An alternate possibility, that is consistent with our
previously published data, is that CaM KIVactivates a substrate
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CBP. The inability to recruit CBP to the promoter of GATA-2
target genes would then lead to a loss of histone acetylation, and
thus gene silencing. This scenario also seems unlikely, however,
since only a small fraction of overexpressed GATA-2 HAwould
be bound to the promoters of target genes and this small pool
would not effectively compete with unbound GATA-2 for the
limiting amounts of CBP that are available in the nucleus. A
final possibility, which we favor based on our results presented
below, is that activation of CaM KIV causes GATA-2 to be
posttranslationally modified in a way that negatively regulates
its activity, and excess GATA-2 is able to overcome this negative
regulation.
If GATA-2 is a direct target of CaM KIV as proposed, then
the ability of ectopic GATA-2 to rescue hematopoietic defects
caused by activation of CaM KIV should be strictly cell-
autonomous. To test this possibility, CaM KIV activity was
upregulated in two dorsal ectodermal cells of eight-cell embryosFig. 7. Mutation of a putative CaM KIV phosphorylataion site in GATA-2 does no
(hGATA-2) and XenopusGata-2 (xGATA-2) surrounding the putative phosphorylated
stage 12 embryos that had been injected with the RNA(s) indicated above each pa
embryos or in embryos that had been injected with wild type (WT) or mutant GATA-
and/or MOs as indicated above each lane. Results were reproduced in two independand RNA encoding GATA-2 HAwas subsequently injected into
these same two cells, or into two ventral ectodermal cells, as
illustrated in Fig. 6E. GATA-2 was able to rescue the loss of
RBCs caused by constitutive activation of CaM KIVonly when
it was expressed in the same cells in which CaM KIV signaling
was upregulated. Taken together, these data demonstrate that
GATA-2 functions downstream of both BMPs and CaM KIV.
Furthermore, our results imply that GATA-2, rather than the
BMP pathway, is the direct target of negative regulation by
CaM KIV.
A putative CaM KIV phosphorylation site in GATA-2 does not
appear to regulate nuclear localization or function
Recent studies have shown that phosphorylation of human
GATA-2 at a potential CaM KIV phosphorylation site (serine
401; illustrated in Fig. 7A) impairs its nuclear translocation and
DNA binding activity (Menghini et al., 2005), raising thet affect nuclear localization or function. (A) Alignment of sequence of human
serine which is underlined. (B) Immunolocalization of GATA-2 HA in stage 7 or
nel. (C, D) Northern blot analysis of expression of Globin in stage 32 control
2 RNA, constitutively active forms of CaM KIVand its upstream kinase (KIVc)
ent experiments.
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thus negatively regulate GATA-2 function during hematopoi-
esis. To begin to test this possibility, we examined nuclear
localization of ectopic GATA-2 in ectodermal cells of Xenopus
embryos in the presence or absence of constitutively active CaM
KIV. RNA encoding GATA-2 HA (200 pg) was injected into a
single blastomere of two-cell embryos either alone, or together
with RNA encoding constitutively active components of the
CaM KIV cascade (50 pg each). The subcellular localization of
GATA-2 was determined by immunostaining whole embryos
with an anti-HA antibody. As shown in Fig. 7B, GATA-2 HA
was distributed throughout the entire cell at the blastula stage
(stage 7) but began to concentrate in nuclei at the start of gas-
trulation (stage 10, data not shown) and was found exclusively
in the nucleus by stage 12. Constitutive activation of the CaM
KIV cascade had no effect on nuclear translocation of GATA-2
HA. Furthermore, mutant forms of Xenopus GATA-2 HA in
which Ser385 (analogous to Ser401 of human GATA-2) was
substituted with aspartate (GATA-2 HAS385D) to mimic
constitutive activation, or with a nonphosphorylable alanine
residue (GATA-2 HAS385A), showed an identical temporal
pattern of cytoplasmic localization followed by nuclear trans-
location (Fig. 7B).
To test the possibility that phosphorylation of Ser385 impairs
the function of GATA-2 independent of nuclear localization, we
asked whether GATA-2 HAS385D was able to rescue the blood
defects caused by either upregulation of CaM KIV or down-
regulation GATA-2. RNA encoding wild type or phosphoryla-
tion mutant forms of rGATA-2 HA (500 pg) was injected into
two dorsal blastomeres of control embryos at the eight-cell stage,
or into embryos that had previously been injected with RNA
encoding constitutively active components of the CaM KIV
cascade (50 pg each) or GATA-2 MOs (6 ng). Embryos were
cultured to stage 32 at which time expression of Globin was
analyzed by Northern blot. As shown in Figs. 7C and D,
overexpression of wild type or phosphorylation mutant forms
of GATA-2 HA did not perturb expression of Globin in control
embryos, thereby ruling out a dominant mutant effect.
Furthermore, we found no difference in the ability of GATA-2
HAS385D to rescue blood formation in embryos in which CaM
KIV was hyperactivated or GATA-2 expression downregulated
relative to wild type GATA-2 HA or GATA-2 HAS385A (Figs. 7C
and D). Taken together, these data demonstrate that CaM KIV
does not impair nuclear translocation of ectopically expressed
GATA-2. Furthermore, whereas a mutation that mimics
constitutive phosphorylation of Ser401 in human GATA-2
impairs its nuclear translocation and function in cultured
preadipocytes (Menghini et al., 2005), the analogous mutation
has no effect on ectodermal GATA-2 nuclear localization or
function in the context of Xenopus primitive hematopoiesis.
Mutation of putative acetylated lysines inactivates GATA-2
in vivo
An alternate mechanism by which CaM KIV could nega-
tively regulate GATA-2, which is consistent with our previous
studies suggesting that constitutive activation of CaM KIVreduces the availability of limiting amounts of CBP (Walters et
al., 2002), is by inhibiting CBPmediated acetylation of GATA-2.
Recent studies have shown that endogenous GATA-2 is
acetylated in vivo and mutation of a subset of lysine residues
that are normally acetylated by the CBP homolog, p300, causes a
severe loss of the transactivation potential of GATA-2
(Hayakawa et al., 2004).
To begin to test the possibility that acetylation of ectoder-
mally derived GATA-2 is required for primitive hematopoiesis,
we generated a series of GATA-2 mutants in which lysine
residues that have been shown to be acetylated in vivo
(Hayakawa et al., 2004) were substituted with arginine. The
location of substituted lysine residues relative to the amino- (N)
and carboxy (C)-terminal zinc finger motifs is illustrated in Fig.
8A. A compound mutant (M1+M2) that includes substitutions
of all lysines present in M1 and M2 was also generated. To rule
out the possibility that the amino acid substitutions caused gross
misfolding, which might destabilize or block nuclear transloca-
tion of GATA-2, wild type and lysine mutant forms of GATA-2
HA were overexpressed in Xenopus embryos and the steady
state level and subcellular distribution of each isoform was
analyzed by Western blotting and whole mount immunostain-
ing, respectively. All mutant GATA-2 HA proteins were present
at levels equivalent to wild type, and were localized to the nuclei
of gastrula stage (stage 12) embryos (data not shown).
To ask whether these GATA-2 variants retained activity in
vivo, we analyzed their ability to rescue RBC number in GATA-
2 morphant tadpoles. GATA-2 MOs (6 ng) were injected into
two dorsal cells of eight-cell embryos followed by injection of
RNA encoding wild type or mutant forms of GATA-2 HA.
Peripheral blood was collected and analyzed when embryos
reached stage 42. As shown in Fig. 8B, M1 and M2 mutants
rescued RBC number to the same levels as wild type GATA-2,
whereas the compound M1+M2 mutant, and the M3 mutant
completely lacked rescue activity in this assay. The M3 mutant
did not perturb blood development when overexpressed in wild
type embryos (Figs. 8B, C). A similar result was obtained when
we analyzed the ability of the putative acetylation mutants to
rescue hematopoietic defects caused by constitutive activation
of Cam KIV with one exception: the M2 mutant was unable to
rescue blood formation in embryos in which Cam KIV was
hyperactivated (Fig. 8C). This observation was unexpected
given that the M2 variant completely rescued the loss of RBCs
caused by knock down of GATA-2 expression (Fig. 8B).
As a final test of our model in which CaM KIV negatively
regulates GATA-2 by reducing the availability of limiting
amounts of the acetyltransferase, CBP, we asked whether we
could rescue blood development in embryos in which CaM
KIV had been constitutively activated by co-expression of
CBP. RNA encoding CBP (25–200 pg) was injected into two
dorsal blastomeres of eight-cell embryos either alone, or
together with RNAs encoding constitutively active components
of the CaM KIV cascade (50 pg each). Embryos were cultured
to stage 34 and expression of Globin was analyzed by Northern
blot. Levels of Globin transcripts in embryos injected with 25
or 50 pg of CBP RNA alone were roughly equivalent to those
in control embryos, and the same dose of CBP reproducibly
Fig. 8. Mutation of putative acetylated lysines inactivates GATA-2 in vivo. (A)
Alignment of sequence surrounding the N- and C-terminal zinc fingers (NF; N-
Finger, CF; C-Finger) of mouse (mGATA-2) and Xenopus Gata-2 (xGATA-2).
Acetylated lysine residues that were mutated in the studies of Hayakawa et al.
(2004) or in the current studies are underlined. (B, C) Mean number (±S.E.M.)
of RBCs present in tadpoles derived from embryos that had been injected with
the RNAs and/or MOs indicated below each bar, expressed as a percentage of
cell number in control embryos. Results are pooled from a minimum of 4
independent experiments. (D) Two dorsal animal pole blastomeres of eight-cell
embryos were injected with varying amounts of RNA encoding CBP alone
(control) or together with constitutively active CaM KIV (KIVc) and expression
of Globin was analyzed by Northern blot at stage 32. Levels of Globin trans-
cripts, normalized relative to levels of Odc transcripts, are expressed as a
percentage of control below each lane. Similar results were obtained in a dupli-
cate experiment.
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had been constitutively activated (Fig. 8D). Higher doses of
CBP alone repressed expression of Globin in control embryos
(data not shown), consistent with previously published studies
(Walters et al., 2002). Taken together, our data are consistent
with the hypothesis that acetylation of GATA-2 is essential for
its function in regulating transcription of ectodermal targetgenes that are required for normal erythropoiesis, and that
activation of CaM KIV inhibits CBP mediated acetylation of
endogenous GATA-2. Unfortunately, the lack of antibodies that
recognize endogenous GATA-2 prevents us from definitively
testing this hypothesis at present.
Discussion
In the current study, we have shown that ectodermal GATA-2
is required for the differentiation, but not for the specification,
of RBC progenitors. Our data are consistent with previously
published work suggesting that Gata-2 is a transcriptional
target of BMPs (Friedle and Knochel, 2002; Maeno et al., 1996;
Walmsley et al., 1994). Furthermore, our data suggest that
acetylation is important for the biological function of GATA-2
in the ectoderm, and that upregulation of CaM KIV signaling
inhibits erythropoiesis by negatively regulating this essential
posttranslational modification.
Role of non-cell-autonomous signals in regulating vertebrate
primitive erythropoiesis
Signaling between neighboring tissues is crucial for proper
embryonic development. In vertebrates, blood originates from
the mesoderm but extrinsic signals derived from adjacent
tissues are known to be essential for normal hematopoiesis. In
Xenopus, for example, signals produced by ectodermal cells
must be transmitted to the mesoderm during gastrulation to
enable these cells to form blood (Maeno, 2003). Our data
demonstrate that BMPs (Walters et al., 2002) and GATA-2 are
required to generate these signals. In mice and chick, primitive
(visceral) endoderm (VE), which is a secretory epithelium that
signals to the nascent mesoderm, may play a role analogous to
the ectoderm in Xenopus since it has been shown to be crucial
for the development of primitive blood (reviewed by Baron,
2003). Specifically, when pre- or early-gastrula stage mouse
embryos are stripped of their VE, the adjacent posterior
mesodermal cells, which normally differentiate as primitive
erythrocytes, are unable to do so (Belaoussoff et al., 1998).
Recombination with VE, however, restores their ability to form
blood. By the midstreak stage (embryonic day 6.75), meso-
dermal explants can differentiate as RBCs when cultured in
isolation, suggesting that the blood-inducing signal from the VE
is transmitted prior to this time (Belaoussoff et al., 1998).
Whether the non-cell-autonomous signals necessary for blood
formation in mouse are identical to those in Xenopus, and
whether BMPs and/or GATA-2 play any role in activating these
signals is unknown. Intriguingly, BMPs are required to signal to
the VE to generate a non-cell-autonomous signal that enables
adjacent mesoderm in the posterior epiblast to form primordial
germ cells (De Sousa Lopes et al., 2004; Gu et al., 1999).
Expression of Gata-2 has been reported as early as E7.5 in the
lateral mesoderm and extraembryonic ectoderm (Minegishi et
al., 1999), but it is not known if it is expressed in the VE at
earlier stages, or whether its expression is dependent on BMPs.
Gata-2 is required for both primitive and definitive hematopoi-
esis, and chimeric analysis, as well as in vitro differentiation
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in definitive blood progenitors (Tsai et al., 1994). Whether it
also plays a non-cell-autonomous role, analogous to that of
Xenopus Gata-2, remains to be investigated.
Despite strong evidence that non-cell-autonomous signals
are required for mesodermal cells to differentiate as blood
during vertebrate embryogenesis, the molecular nature of these
signal(s) remains obscure. BMPs are strong candidates for
fulfilling this role since they can mimic the ectodermally
derived signals required for blood development in Xenopus
(Maeno et al., 1994b). Furthermore, when the intracellular BMP
signal transduction cascade is blocked in ectodermal cells of
whole embryos, erythrocytes fail to develop (Kumano et al.,
1999; Walters et al., 2002). Because BMPs function in a
positive feedback loop to maintain their own expression, these
blood defects have been attributed to a loss of expression of
ectodermally derived BMP, which was proposed to signal to
neighboring mesoderm to enable it to form blood (Kumano et
al., 1999). The current studies, however, suggest that BMP
functions upstream of, rather than providing the ectodermally
derived signal(s) that is required for normal erythropoiesis. We
show that overexpression of GATA-2 in ectodermal cells can
rescue blood development in embryos in which BMP signals are
blocked, whereas activation of the BMP pathway in mesoder-
mal cells cannot rescue erythropoiesis in isolated ventral
mesoderm or in GATA-2 morphants. These findings are con-
sistent with a model in which BMPs are required to activate
transcription of Gata-2 which subsequently regulates expres-
sion of a novel non-cell-autonomous signaling molecule that is
essential for erythropoiesis. Similar to our findings in Xenopus
embryos, recent studies have shown that BMP-4 function is
required upstream, and not downstream of GATA-2 for normal
generation of embryonic stem cell-derived hemangioblasts and
erythroid cells (Lugas et al., 2007). Our results do not rule out
the possibility that ectodermally derived BMPs are required for
hematopoiesis, but they do show that loss of expression of
Bmps is not the underlying cause of the blood defects observed
in embryos in which reception of BMP signals or expression of
Gata-2 is blocked in ectodermal cells.
Xenopus steel/stem cell factor (SCF) is an excellent
candidate for a cytokine that functions downstream BMPs and
GATA-2 to regulate blood development. Consistent with this
idea, we have recently shown that depletion of SCF from
ectodermal cells, or introduction of a dominant mutant form of
its cognate receptor (c-kit) into mesodermal cells, blocks normal
primitive erythropoiesis (Goldman et al., 2006). Preliminary
studies, however, have failed to provide evidence that ex-
pression of SCF requires BMP or GATA-2 function (Goldman
et al., 2006). Further studies will be required to identify
transcriptional targets of GATA-2 within ectodermal cells that
regulate primitive erythropoiesis.
BMPs function in different tissues at multiple developmental
stages to regulate hematopoiesis
Commitment of cells to the hematopoietic lineage is initiated
by ventral patterning of the mesoderm during gastrulation, aprocess that requires BMPs (Nieto, 1999). When endogenous
BMP signaling is blocked by introduction of BMP inhibitors
into ventral cells of Xenopus embryos, ventral tissues, including
blood, fail to differentiate and a secondary dorsal axis is induced
(Kumano et al., 1999; Maeno et al., 1994a; Zhang and Evans,
1996). Furthermore, Bmp-4 mutant mice lack posterior
mesoderm and primitive blood cells (Winnier et al., 1995)
while zebrafish embryos mutant for Bmp-2b (Kishimoto et al.,
1997; Mullins et al., 1996; Nguyen et al., 1998) or Bmp7 (Dick,
2000 #398; Schmid et al., 2000) show a dorsalized phenotype
accompanied by a decrease in RBCs. Conversely, Xenopus
embryos made to ectopically express BMP-4, or zebrafish
embryos mutant for BMP antagonists, show an expanded
domain of expression of erythroid-specific genes in whole
embryos. Thus, high levels of BMP signaling are required
during gastrulation to specify ventroposterior fates, including
blood (reviewed by Davidson and Zon, 2000).
GATA-2, or another member of the GATA family, has been
proposed to cooperate with BMP-4 in ventral patterning of the
mesoderm (Sykes et al., 1998). This hypothesis is based on
studies showing that overexpression of a dominant interfering
GATA factor, consisting of the GATA-2 DNA binding domain
fused to the engrailed repressor domain, phenocopies the
dorsalization observed when BMP function is blocked in Xe-
nopus embryos (Sykes et al., 1998). We find, however, that
overexpression of this fusion protein in ectodermal cells of
Xenopus embryos does not phenocopy the hematopoietic
defects observed in GATA-2 morphants, and GATA-2 mor-
phants do not show any signs of dorsalization (Dalgin and
Christian, unpublished data). These results demonstrate that
Gata-2 is not required for ventral mesodermal fate and raise
questions as to whether the GATA–engrailed fusion protein
specifically targets, and/or is capable of targeting all GATA
family members. Chimeric proteins consisting of the engrailed
repressor domain fused to the DNA binding domain of a
number of different transcription factors, including multiple
GATA family members (Sykes et al., 1998), STAT1, 3 or 5
(Nishinakamura et al., 1999), Xlmo4 (De la Calle-Mustienes et
al., 2003), CBTF (Scarlett et al., 2004) and Xpcl1 (Yoshitake
and Christian, unpublished data) can all induce dorsalization
when overexpressed in Xenopus embryos. Given these findings,
the specificity of this phenotype must be interpreted with
caution.
A number of recent studies, in addition to the current one,
have identified roles for BMPs in hematopoiesis that are
independent of their early function in specifying ventroposterior
fate in the mesoderm. BMPs, for example, have been shown to
be required during mid- to post-gastrula stages for specification
of myeloid fate. Specifically, zebrafish embryos mutant for the
BMP receptor, Alk8, or embryos in which BMP function is
removed at the bud stage, well after dorsoventral pattern is
established, lack the pool of myeloid cells that are normally
derived from anterior lateral plate mesoderm (Hogan et al.,
2006). Conversely, embryos in which BMP signaling is
upregulated at doses that do not affect dorsal patterning show
an increase in the number of myeloid cells (Hogan et al., 2006;
Walters et al., 2002). Finally, recent studies have shown that
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the lateral mesoderm during somitogenesis (Gupta et al., 2006;
Pyati et al., 2005). Although we and others (Rhodes et al.,
2005) find no evidence that GATA-2 is required for myeloid
fate, it remains possible that it functions downstream of BMPs
in the lateral mesoderm.
CaM KIV regulates GATA-2 posttranslationally
Transcription factors are tightly regulated at transcriptional,
posttranscriptional and posttranslational levels, and our results
suggest that GATA-2 is posttranslationally modified down-
stream of CaM KIV. The most obvious modification that might
occur in response to upregulation of CaM KIV is phosphoryla-
tion. Consistent with this possibility, human GATA-2 is
phosphorylated at a potential CaM KIV site (Serine401) in a
PI-3K/Akt-dependent manner in transfected HEK293 cells and
this negatively regulates its activity (Menghini et al., 2005).
Specifically, phosphorylated GATA-2, or a mutant form of
GATA-2 in which serine 401 is substituted with aspartate to
mimic phosphorylation, is unable to undergo nuclear transloca-
tion in HEK293 cells, or to block adipocyte differentiation
when overexpressed in a cultured preadipocyte cell line. By
contrast, our current data show that ectopic GATA-2 carrying
an analogous serine to aspartate substitution undergoes proper
temporally regulated nuclear translocation in Xenopus
embryos, and is able to rescue hematopoietic defects in
GATA-2 morphants. Thus, a phosphorylation event that can
control the nuclear localization and function of GATA-2 in
cultured HEK cells and preadipocytes does not appear to be
capable of regulating GATA-2 function in vivo in the context of
Xenopus primitive hematopoiesis. Phosphorylation of other
GATA family members has been shown to either suppress or
enhance their ability to regulate expression of specific target
genes when overexpressed in cultured cells, but, as with
GATA-2, the in vivo importance of phosphorylation is unclear.
GATA-1, for example, is phosphorylated at seven different
serine residues, either constitutively or in response to
extracellular signals, and yet mice carrying serine-to-alanine
mutations at three of these sites do not show hematological
defects indicative of impaired GATA function (Rooke and
Orkin, 2006).
Acetylation represents another important posttranslational
modification that is crucial for the activity of GATA family
members (reviewed by Huo and Zhang, 2005). GATAs recruit
histone acetyl transferases (HATs) to chromatin, leading to
histone acetylation, and this alters chromatin structure enabling
target genes to be transcribed. GATA proteins can also serve as
direct substrates for HATs, and this modification is essential
for their transactivation potential. GATA-2, for example, is
known to bind CBP (Blobel et al., 1998) and has been shown
to be acetylated in hematopoietic progenitor cells by the CBP
homolog, p300 (Hayakawa et al., 2004). Mutant forms of
GATA-2 in which the predominant acetylated lysines are
substituted with alanines have severely reduced transactivation
activity, although they retain the ability to interact with p300
suggesting that the loss of activity is not due to an inabilityto recruit this transcriptional coactivator to histones. Notably,
although several of the lysine mutants retain the ability to bind
DNA, all are non-functional as assayed by their ability to
inhibit growth of IL-3-dependent hematopoietic progenitor
cells (Hayakawa et al., 2004). In the current studies, we
provide the first evidence that acetylation of GATA-2 is
required for erythropoiesis in a whole animal model.
Model for interactions between BMPs, CaM KIV and GATA-2
during primitive hematopoiesis
Taken together, our current and previous (Walters et al.,
2002) data suggest a molecular mechanism by which BMPs,
CaM KIV and GATA-2 interact within ectodermal cells to
regulate primitive hematopoiesis (illustrated in Fig. 9).
According to our model, GATA-2 is a direct transcriptional
target downstream of BMP receptor activation within ectoder-
mal cells, while activation of the CaM KIV signaling pathway
alters GATA-2 function posttranslationally. We hypothesize that
under physiological conditions, sufficient CBP is present to
acetylate GATA-2 so that it can activate transcription of target
gene(s) that encode secondary signaling molecules that are
required for mesoderm to form blood (Fig. 9A). When CaM
KIV is hyperactivated, however, high levels of phosphorylated
substrate accumulate and this phosphorylation event enables
them to recruit limiting amounts of CBP away from endogenous
GATA-2. This leads to hypoacetylation of GATA-2, and an
inability to activate transcription of target genes that are
required for hematopoiesis (Fig. 9B).
The idea that upregulation of CaM KIV activity leads to
sequestration of limiting amounts of CBP is based primarily on
our previously published studies but has precedent in that
others have shown that competition for binding to limiting
amounts of CBP can regulate gene transcription (Chakravarti et
al., 1996; Kamei et al., 1996; Takahashi et al., 2000). In our
original model, we proposed that CBP bound to and functioned
as a co-activator for a hematopoietic specific transcription
factor (e.g. GATA-2) by acetylating histones at the promoter of
its target genes. The ability of overexpressed GATA-2 to rescue
hematopoiesis in embryos in which CaM KIV is activated
argues against this possibility, however, since excess free
GATA-2 would effectively squelch the activity of the small
pool of CBP bound GATA-2. In the current model, we propose
instead that CBP functions catalytically to acetylate GATA-2
rather than requiring a one-to-one stoichiometry of binding to
function. In this scenario, overexpressed GATA-2 would
require only a transient interaction with CBP to become
functional. Our data showing that mutant forms of GATA-2 that
cannot be acetylated are unable to rescue hematopoiesis in
embryos in which CaM KIV is hyperactivated are consistent
with this model, but definitive proof will require the
development of antibodies that recognize endogenous acety-
lated GATA-2 in vivo.
The observation that certain lysine mutant forms of GATA-
2 (M2) can fully rescue erythropoiesis in GATA-2 morphants,
but not in embryos in which CaM KIV is upregulated demon-
strates that loss of activity in the latter case is not due to gross
Fig. 9. Model for regulation of ectodermal GATA-2 by BMPs and CaM KIV during primitive hematopoiesis. Activation of the BMP signal transduction cascade in
ectodermal cells is required to activate transcription of GATA-2. Under normal conditions, GATA-2 is acetylated by CBP and this enables it to regulate transcription of
target genes, including those that are required for normal primitive hematopoiesis (left panel). When CaM KIV is hyperactivated, it phosphorylates excessive amounts
of a substrate which can then recruit limiting amounts of CBP away from GATA-2. Under these conditions, GATA-2 is hypoacetylated and can no longer activate
transcription of target genes (right panel).
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One simple explanation for these findings, which is consistent
with our model, is that acetylation of both of the lysines
targeted in the M2 mutant is sufficient for GATA-2 activity
whereas loss of acetylation of all four lysines (M1+M2) leads
to loss of activity. In GATA-2 morphants, sufficient CBP is
available to acetylate all of the available lysines in ectopically
expressed GATA-2, whereas in embryos made to express
constitutively active CaM KIV, only a subset of available
lysines may be acetylated. In these embryos, hypoacetylated
wild type GATA-2 may be fully active whereas hypoacetyla-
tion, in combination with loss of availability of the M2
lysines for acetylation may be sufficient to block transactiva-
tion potential.
BMPs, CaM KIV, and GATA family members may interact
during patterning of additional organs outside of the hemato-
poietic system. We have shown that inhibition of BMP function
or hyperactivation of CaM KIV in dorsal mesodermal cells (but
not ectodermal cells) of Xenopus embryos leads to heart and
gut defects that are similar to those observed in animals in
which GATA-4, -5 and/or -6 function has been perturbed
(Peterkin et al., 2005; Walters et al., 2001, 2002; Wayman et al.,
2000). Mice or frogs lacking Gata-4, for example, or fish
mutant for Gata-5 display cardia bifida (reviewed by Molk-
entin, 2000), and, in mice, this can be rescued by restoring
Gata-4 expression in the endoderm (Narita et al., 1997).Inhibition of BMP signaling or activation of CaM KIV in the
endoderm of Xenopus embryos also leads to cardia bifida
(Walters et al., 2001). In addition, Xenopus embryos in which
BMP signals are blocked, or CaM KIV activity is upregulated
in dorsal mesoderm and endoderm show defects in gut looping
and endodermal differentiation (Walters et al., 2002) similar to
those observed in GATA-5 and/or 6 morphants (Afouda et al.,
2005). Within the endoderm and cardiac mesoderm, GATA
factors and BMPs have been shown to regulate each other's
expression and to cooperatively regulate transcription of target
genes. For example, Gata-4 and Gata-6 are expressed down-
stream of BMPs and both of these genes are required to
maintain transcription of Bmp-4 (reviewed by Peterkin et al.,
2003). Furthermore, GATA-4 and the intracellular transducers
of BMPs, SMAD-1 and SMAD-4, can physically interact and
are required for transcription of the cardiac-specific transcrip-
tion factor Nkx2.5 (reviewed by Brown et al., 2004; Peterkin et
al., 2005).
Loss of function analyses clearly demonstrate that GATA
and BMP pathways interact in multiple organ systems,
including the ectoderm, whereas evidence that endogenous
CaM KIV can regulate GATA function is currently lacking.
Mice mutant for CaM KIV have defects in maintenance of adult
hematopoietic stem cells (Kitsos et al., 2005) and in learning
and memory (Ahn et al., 1999), but primitive hematopoiesis
has not been evaluated in these mutants. The current studies
468 G. Dalgin et al. / Developmental Biology 310 (2007) 454–469demonstrate that ectodermal GATA-2 is required for primitive
hematopoiesis and clarify the mechanism by which hyperacti-
vation of CaM KIV disrupts this function in vivo.
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